NCT00174291View on ClinicalTrials.gov

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

PHASE3TerminatedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Endocrine System Diseases

Interventions

DRUG

Somatropin

Liquid, daily to final height Maximum Dosage: 50 µg/kg/day

Trial Locations (1)

75019

Pfizer Investigational Site, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY